Abstract:ABSTRACT Mounting evidence has revealed the association between gut microbiota and both chronic obstructive pulmonary disease (COPD) and asthma; however, the causal association between gut microbiota and specific disease phenotypes remains to be determined. This study employed bidirectional two-sample Mendelian randomization (MR) analyses to investigate the potential causal relationship between gut microbiota and these conditions. The research utilized genome-wide association study (GWAS) data from the MiBioGen consortium for gut microbiota and the integrative epidemiology unit (IEU) Open GWAS for these conditions. Four MR analysis methods were employed: the inverse variance weighted (IVW) test, MR-Egger, weighted median, and weighted mode methods. The IVW method results are considered the primary findings. Sensitivity analyses, including heterogeneity tests, horizontal pleiotropy analysis, and leave-one-out analysis, were used to enhance robustness. Our MR study identified eight gut microbiota taxa potentially associated with the risk of different types of COPD and asthma. These include two taxa for early-onset COPD: Streptococcaceae [odds ratio (OR) = 1.315, 95% confidence interval (CI) = 1.071–1.616, P = 0.009] and Holdemanella (OR = 1.199, 95% CI = 1.063–1.352, P = 0.003); three for later-onset COPD: Acidaminococcaceae (OR = 1.312, 95% CI = 1.098–1.567, P = 0.003), Holdemania (OR = 1.165, 95% CI = 1.039–1.305, P = 0.009), and Marvinbryantia (OR = 0.814, 95% CI = 0.697–0.951, P = 0.009); one for allergic asthma: Butyricimonas (OR = 0.794, 95% CI = 0.693–0.908, P = 0.001); and two for non-allergic asthma: Clostridia (OR = 1.255, 95% CI = 1.043–1.511, P = 0.016) and Clostridiales (OR = 1.256, 95% CI = 1.048–1.506, P = 0.014). IMPORTANCE Individuals with diverse phenotypes of chronic obstructive pulmonary disease (COPD) and asthma exhibit different responses to the conventional “one treatment fits all” approach. Recent research has revealed the significant role of the gut-lung axis in both COPD and asthma. However, the specific impact of gut microbiota on different subtypes of these conditions remains poorly understood. Our study has identified eight gut microbiota that may be associated with the risk of different types of COPD and asthma. These findings provide evidence suggesting a potential causal relationship between gut microbiota and various phenotypes of COPD and asthma. This offers a new perspective on the origins of different disease phenotypes and points toward future exploration of phenotype-specific and personalized therapies.

Assessing causal relationships between gut microbiota and asthma: evidence from two sample Mendelian randomization analysis

Genetic evidence on the causality between gut microbiota and various asthma phenotypes: a two-sample Mendelian randomization study

Unveiling genetic links between gut microbiota and asthma: a Mendelian randomization

Mendelian randomization analysis identifies intestinal flora causally associated with asthma-related infections and pneumonia

Association of the gut microbiome and different phenotypes of COPD and asthma: a bidirectional Mendelian randomization study

Genetic liability to asthma and risk of cardiovascular diseases: A Mendelian randomization study

The associations between gut microbiota and chronic respiratory diseases: a Mendelian randomization study

Genetic evidence of bidirectional mendelian randomization study on the causality between gut microbiome and respiratory diseases contributes to gut-lung axis

Investigating causal relationships between the gut microbiota and allergic diseases: A mendelian randomization study

Genetic association and bidirectional Mendelian randomization for causality between gut microbiota and six lung diseases

Gut microbiota and risk of lower respiratory tract infections: a bidirectional two-sample Mendelian randomization study

Causal associations between pediatric asthma and united airways disease: a two-sample Mendelian randomization analysis

The causality between intestinal flora and allergic diseases: Insights from a bi-directional two-sample Mendelian randomization analysis

Causal effects of genetically determined blood metabolites on asthma: a bidirectional Mendelian randomization study

Causal effects between gut microbiota and pulmonary arterial hypertension: A bidirectional Mendelian randomization study

Mendelian randomization study of childhood asthma and chronic obstructive pulmonary disease in European and East Asian population

Evidence of the association between asthma and lung cancer risk from mendelian randomization analysis

Causal association between air pollution and allergic rhinitis, asthma: a Mendelian randomization study

Causal Relationship Between Gut Microbiota and Chronic Obstructive Pulmonary Disease: A Bidirectional Two-Sample Mendelian Randomization Study

Causal Link between Human Blood Metabolites and Asthma: An Investigation Using Mendelian Randomization

Revealing a causal relationship between gut microbiota and lung cancer: a Mendelian randomization study